Masoud Maher 4
4 · MAXCYTE, INC. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Masoud Maher
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-14+347,500→ 347,500 totalExercise: $3.29Exp: 2035-03-13→ Common Stock (347,500 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares underlying this option shall vest on March 14, 2026, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.